Interestingly, despite the known confounding effect of MMR status on immunological responses in colorectal cancer, comprehensive analyses of cell types involved in immune response and inflammation have not yet been systematically performed for MMR-proficient cancers, encompassing 85% of all colorectal cancer cases. Here, MRC1 is linked to cancer.